145 related articles for article (PubMed ID: 22716492)
1. Schistosomiasis and bladder cancer: similarities and differences from urothelial cancer.
Zaghloul MS; Gouda I
Expert Rev Anticancer Ther; 2012 Jun; 12(6):753-63. PubMed ID: 22716492
[TBL] [Abstract][Full Text] [Related]
2. Bladder cancer and schistosomiasis.
Zaghloul MS
J Egypt Natl Canc Inst; 2012 Dec; 24(4):151-9. PubMed ID: 23159285
[TBL] [Abstract][Full Text] [Related]
3. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
4. Does Schistosoma-associated bladder cancer differ from urothelial cancer? Proof from the laboratory and clinic.
Zaghloul MS
Cancer Genet Cytogenet; 2008 Jan; 180(2):160-2. PubMed ID: 18206545
[No Abstract] [Full Text] [Related]
5. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.
Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S
Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480
[TBL] [Abstract][Full Text] [Related]
8. Small cell carcinoma of the bladder associated with schistosomiasis: a case report.
Almeida M; Canas-Marques R; Lopez-Beltran A; Rebola J; Lúcio R; Montironi R; Cheng L; Fonseca J
Anal Quant Cytopathol Histpathol; 2014 Dec; 36(6):339-44. PubMed ID: 25803993
[TBL] [Abstract][Full Text] [Related]
9. Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors.
Takahashi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Kato T; Ogawa O; Habuchi T
J Urol; 2001 Feb; 165(2):672-7. PubMed ID: 11176456
[TBL] [Abstract][Full Text] [Related]
10. Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
Shaker OG; Hammam O; Salehd A; el-Leithy T; Wishahi M
Clin Biochem; 2009 Jun; 42(9):864-72. PubMed ID: 19272297
[TBL] [Abstract][Full Text] [Related]
11. Urothelial carcinoma.
Merseburger AS; Shariat SF
World J Urol; 2011 Aug; 29(4):405-7. PubMed ID: 21779833
[No Abstract] [Full Text] [Related]
12. Behavior of urothelial carcinoma with respect to anatomical location.
Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
[TBL] [Abstract][Full Text] [Related]
13. [Anatomopathological aspects of 25 cases of bilharzial bladder cancer].
Nouhou PH; Mossi A
Bull Soc Pathol Exot; 1996; 89(3):181-4. PubMed ID: 8998411
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic profile of locally advanced and metastatic Schistosoma-related bladder cancer and response to chemotherapy.
Aly MS; Khaled HM; Emara M; Hussein TD
Cancer Genet; 2012 Apr; 205(4):156-62. PubMed ID: 22559976
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
[TBL] [Abstract][Full Text] [Related]
16. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
17. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A
Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250
[TBL] [Abstract][Full Text] [Related]
18. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
[TBL] [Abstract][Full Text] [Related]
19. Revisiting cercariform cells: Small cell carcinoma masquerading as cercariform cells.
El Hussein S; Colanta A; Khader SN
Diagn Cytopathol; 2019 Oct; 47(10):1072-1075. PubMed ID: 31386301
[TBL] [Abstract][Full Text] [Related]
20. Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.
Dominick MA; White MR; Sanderson TP; Van Vleet T; Cohen SM; Arnold LE; Cano M; Tannehill-Gregg S; Moehlenkamp JD; Waites CR; Schilling BE
Toxicol Pathol; 2006; 34(7):903-20. PubMed ID: 17178691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
